drugset / Trial / NCT00619190
Study of Aripiprazole to Treat Children and Adolescents With Autism
Phase 2
Completed
30 enrolled
University of North Carolina, Chapel Hill
Bristol-Myers Squibb · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this open label study in children and adolescents is to examine the acute and long-term effects of aripiprazole on problem behaviors associated with autism spectrum disorders and development in areas which appear to be affected by autism spectrum disorders.
Timeline
- Start
- 2006-01
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 1 mg | — |
| Subject | Aripiprazole | Other / unclassified | 30 mg | — |